Coulter Partners

About Us

We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.

Achievements

Recent Placements

Coulter Partners

Find a Recruiter

0

The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.

Our Team

Coulter Partners

Solutions And Expertise

Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database.  Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.

Solutions
  • Advisory Services
  • Assessment
  • Board Services
  • Culture Shaping
  • Data Analy./Mrkt. Intell.
  • Diversity & Inclusion
  • Executive Coaching
  • Executive Search
  • Leadership Consulting
  • Leadership Develop.
  • Mgmt. Consulting
  • Onboarding
  • Recruitment Research
  • Succession Planning
Industries
  • Agriculture
  • Biotechnology
  • Chemicals
  • Clean Tech./Sustain.
  • Clinical Research
  • Consulting
  • Consumer
  • Consumer Products
  • Consumer Services
  • Data & Analytics
  • Devices
  • Energy
  • Family Offices
  • Financial Services
  • FinTech
  • Foundations
  • Healthcare Services
  • High Tech
  • Industrial
  • Industrial Products
  • Internet
  • Life Sci./Healthcare
  • Machine Learning
  • Medical
  • Medical Devices
  • Natural Resources
  • Non-Profit
  • Pharmaceuticals
  • Private Equity
  • Professional Services
  • Software
  • Supply Chain
  • Technology
  • Venture Capital
Functions
  • Board/Governance
  • Business Development
  • CEO/President
  • Data/Analytics
  • Diversity & Inclusion
  • Finance/Accounting
  • General Management
  • GM/Operations
  • Human Resources
  • Information/Digital
  • Investor Relations
  • Legal/Compliance
  • Manufacturing
  • Marketing & Sales
  • Medical/Clinical
  • Research & Develop.
  • Supply Chain

Coulter Partners

News Briefings

Coulter Partners Recruits Chief Scientific Officer for Biomia 

Life sciences recruiting specialist Coulter Partners has placed Frederick Westhorpe as chief scientific officer of Biomia. “We are excited to welcome Frederick to Biomia, and confident that his extensive small molecule drug discovery and development expertise will complement the team and guide our company’s next phase of strategic growth,” said Michael Krogh Jensen, Biomia’s co-founder and CEO.

Coulter Partners Places Biotech Entrepreneur as CEO of Nuage Therapeutics

Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Stuart Hughes as CEO of Nuage Therapeutics. “Coulter Partners has been an invaluable partner in this crucial appointment for Nuage Therapeutics,” said Vanessa Malier, chair of the board of directors of Nuage Therapeutics. “Their team demonstrated exceptional dedication and a truly collaborative spirit, working closely

Coulter Partners Recruits Chief Data and Technology Officer for Clinical Partners

Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Luis De Miguel Puig as chief data and technology officer of Clinical Partners. “Coulter Partners truly understood our requirements for a leader who could champion automation, self-service, and data-driven strategy,” said Barny Guthrie, CEO at Clinical Partners. “They delivered an impressive, diverse shortlist in under 30 days,

Coulter Partners Recruits Chief Scientific Officer for ExpressionEdits

Life sciences recruiting specialist Coulter Partners has helped to recruit Amrik Basran as chief scientific officer of ExpressionEdits. “Amrik’s extensive experience in biologics development makes him an invaluable addition to ExpressionEdits,” said Kärt Tomberg, co-founder and CEO of ExpressionEdits. “His leadership will be key as we expand from platform innovation to therapeutic development, ensuring our technology

Coulter Partners

Press Releases

Coulter Partners places renowned scientific leader Dr. Adam Davenport as CSO at Concept Life Sciences

Coulter Partners successfully led a search assignment for Concept Life Sciences and is pleased to announce the placement of Dr. Adam Davenport as Chief Scientific Officer (CSO). Concept Life Sciences is a leading global contract research organization (CRO) specializing in integrated drug discovery, development, and analytical services. The company provides consultative and collaborative solutions that enable

Coulter Partners successfully led a search assignment for Kaffe Bueno and is pleased to announce the placement of Thomas Durhuus as Chief Executive Officer (CEO)

Kaffe Bueno is a Danish bioscience company and certified B Corp that upcycles coffee by-products into high-performance, active, and functional ingredients. Using green chemistry and biotechnology, the company unlocks the full potential of coffee by-products to provide sustainable, natural solutions for the personal care, nutraceutical, food, and industrial sectors. As CEO, Thomas will lead Kaffe Bueno

Coulter Partners Places Industry Veteran Mark Rothera as CEO of TreeFrog Therapeutics

Coulter Partners successfully led a search assignment for TreeFrog Therapeutics and is pleased to announce the placement of Mark Rothera as Chief Executive Officer (CEO). TreeFrog Therapeutics is a French regenerative medicine biotech focused on providing mass access to cell therapies. By combining biophysics and engineering, they produce high-quality cells at unprecedented scale and cost-effectiveness through internal programs and strategic

Coulter Partners places Daniel Green as Chief Operating Officer at mOm Incubators

Coulter Partners successfully led a search assignment for mOm Incubators Ltd (“mOm”) and is pleased to announce the placement of Daniel Green as Chief Operating Officer (COO). mOm is a pioneering UK-based health-tech company dedicated to transforming neonatal care. Its flagship product, the mOm Essential Incubator, is a world-first, lightweight, and portable device designed to maintain

Coulter Partners successfully led a search assignment for Trevi Therapeutics, Inc. (Nasdaq: TRVI) and is pleased to announce the placement of David Hastings as Chief Financial Officer (CFO)

Trevi Therapeutics is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC). David Hastings brings over 25 years of financial leadership in the public life sciences and biopharmaceutical